Definitive Contract HHSN272201700022C
Award Date 6/1/17
Potential Completion Date 5/31/24
Potential Value $19M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
New Orleans, LA 70112, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Administrators Of The Tulane Educational Fund, doing business as Tulane University. The contract is for a study with the ID "CONDUCT STUDY P223" and has a ceiling value of $2,180,168.00. It is a delivery order under the Simian Vaccine Evaluation Units master IDIQ contract. The contract does not have a set-aside designation and has an ultimate completion...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $9,705,349.83 Definitive Contract to The Administrators of the Tulane Educational Fund, doing business as Tulane University, a private non-profit university in New Orleans, Louisiana. This non-severable base period contract runs from September 30, 2018 to September 29, 2019, with a completion date of July 14, 2024. The contract has a Cost No Fee pricing type...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $645,369.00 delivery order to The Administrators of the Tulane Educational Fund, doing business as Tulane University, on August 5, 2019. The award, which is not set aside, is for the Conduct Study P209 under the Simian Vaccine Evaluation Units 2013-2020 master contract vehicle. Tulane University, a private non-profit university located in New...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to The Administrators of Tulane Educational Fund, doing business as Tulane University. The contract is a delivery order under the "Simian Vaccine Evaluation Units 2013-2020" indefinite delivery contract, with a ceiling value of $9,035,728.24 and a completion date of April 30, 2022. The contract is for "Simian...
- This is a delivery order award to The Administrators Of Tulane Educational Fund, doing business as Tulane University, under the National Institute of Allergy and Infectious Diseases' (NIAID) Simian Vaccine Evaluation Units master contract. The $1,796,343 award is for a study titled "CONDUCT STUDY P217" with a period of performance through October 30, 2026. The contract does not have a set-aside designation. As a comprehensive research university, Tulane University has extensive...
- This $1,422,288.62 federal delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the Administrators of Tulane Educational Fund, doing business as Tulane University, a private university in New Orleans, Louisiana. The contract is for "Simian Vaccine Evaluation Units" and has an ultimate completion date of June 30, 2020. It is a cost-no-fee contract issued under a...
- This firm fixed price delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to the Administrators of Tulane Educational Fund, the parent organization of Tulane University, a private research university in New Orleans, Louisiana. The $150,000 contract is for animal models of infectious diseases research, as part of NIAID's broader Animal Models of Infectious Diseases 2010-2017 master...
- This federal contract award, valued at $22,632,164.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to The Administrators of Tulane Educational Fund, doing business as Tulane University. The contract is for the operation of the Cellular Immunology Core Laboratory (CICL) to conduct, analyze, develop, optimize, and validate cellular immunologic assays for infectious diseases like HIV, Simian Immunodeficiency Virus, and Mycobacterium tuberculosis. The contract has...
- This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to The Administrators of Tulane Educational Fund, doing business as Tulane University. The $150,969.93 award provides administrative and technical support for ongoing studies and the final transition under the Simian Vaccine Evaluation Units program, which is a major program code associated with this contract. The...
- This is a delivery order contract awarded to The Administrators of Tulane Educational Fund, doing business as Tulane University, by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency. The contract is for the maintenance of nonhuman primates in an Animal Biosafety Level 2/3 (ABSL2/3) facility. The contract has a ceiling value of $1,257,574.07 and runs through March 31, 2027. This contract is a task order under a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal contract award to The Administrators Of The Tulane Educational Fund, doing business as Tulane University, a private university located in New Orleans, Louisiana. The contract, with a ceiling value of $18,887,126.36, was awarded on June 1, 2017 by the National Institute of Allergy and Infectious Diseases, a component of the U.S. Department of Health and Human Services. The contract is for the establishment of a Nonhuman Primate (NHP) Core Cellular Immunology Laboratory to support AIDS vaccine research and development. This is a definitive, cost-no-fee contract with a performance period ending on May 31, 2024. The contract does not have a set-aside designation.
Generated 6/26/24, 9:34 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
NONHUMAN PRIMATE CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT | NIAID-DAIDS-NIHAI2016060 | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 4/1/16, 10:00 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00011 | Funding Only Action | ($1k) | 6/25/24 | |
| P00010 | Other Administrative Action | $1.9m | 8/17/23 | |
| P00009 | Exercise an Option | $0 | 5/24/23 | |
| P00008 | Funding Only Action | ($6k) | 5/27/22 | |
| P00007 | Exercise an Option | $1.9m | 5/9/22 |